Neurotech Solutions

Neurotech solutions is a digital health company focused on eliminating undiagnosed ADHD. The companys mission is to help every person with ADHD lead a better life and fulfill their potential. Neurotech Solutions core technology is a cloud-based, AI-driven online test that looks and feels like a game. The technology was first implemented in a clinical product called MOXO d-CPT, a decision-support tool for the diagnosis of ADHD. Using MOXO d-CPT, a healthcare professional can obtain objective, standardized, comparative results about a patients attentional difficulties in just 14 to 18 minutes. More than 500,000 MOXO tests have been performed to date in over 20 countries. During the COVID-19 pandemic, the company released a home version of MOXO to enable a full remote and objective diagnosis of ADHD. The companys core technology was also implemented in an educational product called AXON-School. Intended for all K-12 children, the product objectively highlights children with attentional difficulties and suggests educational strategies for personalized learning. Neurotech Solutions opened a subsidiary in Guangzhou, China, in 2021.

Neurotech Solutions has raised $3.55M in total funding across 3 rounds. The company is currently at the Mature stage. Key investors include Guangzhou Sino-Israel Biotech Investment Fund (GIBF), Noaber, Impact First Investments.

Neurotech Solutions operates in Health Tech & Life Sciences, Digital Healthcare, Medical Decision Support, with core technologies in Data Storage, Cloud, Artificial Intelligence. Target customers: Education, K12 Education, Healthcare & Life Sciences, Healthcare, Providers, Consumers, Demographics & Family, Children.

Neurotech Solutions is based in Pinkas Street 66, Tel Aviv-Yafo, Israel, Center District. The company also has offices abroad.